Updated hourlyHourly refreshWed, Sep 2, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
GENEVA, SWITZERLAND - September 1, 2026 ( NEWMEDIAWIRE ) - MindMaze Therapeutics Holding SA (SIX: MMTX ) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced its participation in several upcoming investor and industry conferences in the United States and Europe. Investor Conferences Conference: Baader Investment Conference Location: Munich, Germany Presentation: September 21, 2026 at 5:40 p.m. CET Conference: Global Markets Forum Location: New York, NY Presentation: October 7, 2026 Management will be available for one-on-one meetings. Investors interested in meeting with the Company are invited to contact ir@mindmazetherapeutics.com. Industry Conferences Conference: American Medical Rehabilitation Providers Association (AMRPA) Edu
Sep 1 · 21:23·NewMediaWire
AI · SaaS
SAN FRANCISCO, September 01, 2026--Paubox has made its HIPAA compliant forms callable by AI agents. An agent can pull a form's questions, collect a patient's answers in conversation, and submit the completed response into Paubox. The record lands under the same business associate agreement (BAA) that covers the rest of the platform.
Sep 1 · 21:16·mlpr-businesswire
Finance · Healthcare
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced that on September 1, 2026, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 269,000 shares of the Company’s common stock to four (4) newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual’s entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5
Sep 1 · 21:15·GlobeNewswire
Finance · Healthcare
MOUNTAIN VIEW, Calif., September 01, 2026--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in the upcoming 2026 Cantor Global Healthcare Conference.
Sep 1 · 21:01·mlpr-businesswire
Healthcare · Education
(PR-inside.com) Sixty-four dentists complete inaugural two-day implant course with Dr. Timothy Kosinski to earn 12 hours of CE IRVINE, CA / ACCESS Newswire / September 1, 2026 / Glidewell, America's leading dental laboratory and developer of innovative technologies, held its first live course at its Glidewell Clinical Education Center in Raleigh, North Carolina over the weekend, marking the official opening of its new East Coast facility. The inaugural program, Surgical Placement of Dental Implants: A Restorative-Driven Approach, was taught August 28-29 by esteemed educator Timothy F. Kosinski, DDS, and drew 64 attendees, each of whom earned 12 hours of continuing education. Over two days, ..
Sep 1 · 21:00·PR-Inside
Healthcare
SAN CLEMENTE, Calif., September 01, 2026--Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing additional reimbursement for eligible Fee-for-Service Medicare inpatient cases beginning October 1, 2026.
Sep 1 · 21:00·mlpr-businesswire
Healthcare · Education
Sixty-four dentists complete inaugural two-day implant course with Dr. Timothy Kosinski to earn 12 hours of CE
Sep 1 · 21:00·Newswire.com
Healthcare
First case of its kind at Nicklaus Children's Hospital and among only a few in the U.S. MIAMI, Sept. 1, 2026 /PRNewswire/ -- Nicklaus Children's Hospital Helen & Jacob Shaham Cancer & Blood Disorders Institute has successfully accomplished a bone marrow transplant on a 2-year-old girl...
Sep 1 · 20:53·PR Newswire
Healthcare
RAPPERSWIL, SWITZERLAND - September 1, 2026 ( NEWMEDIAWIRE ) - Neovii Pharmaceuticals AG today announced the appointment of Duncan Ferguson as Chief Commercial Officer (CCO) , effective 1 September 2026. Ferguson joins the company at a pivotal stage as Neovii accelerates the global expansion of its transplantation franchise and advances its strategic growth initiatives in immune-mediated diseases. Duncan brings nearly three decades of global commercial leadership experience spanning specialty pharmaceuticals, rare diseases, immunology, oncology and neuroscience. Throughout his career, he has built and scaled international commercial organizations, led successful market expansion strategies, and supported the launch and growth of innovative therapies across multiple regions. Most recently,
Sep 1 · 20:47·NewMediaWire
Finance · Healthcare
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September:
Sep 1 · 20:46·GlobeNewswire
Healthcare
SAN DIEGO, September 01, 2026--Styx Biotechnologies, Inc., a San Diego-based biotechnology company developing next-generation antibody-drug conjugates (ADCs) for solid tumors, today announced a strategic agreement with ZoeNCure Therapeutics Pvt. Ltd. to accelerate selected Styx ADC programs toward first-in-human clinical studies.
Sep 1 · 20:45·mlpr-businesswire
Finance · Healthcare
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
Sep 1 · 20:36·GlobeNewswire